118 related articles for article (PubMed ID: 11291923)
1. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas.
Nio Y; Iguchi C; Yamasawa K; Sasaki S; Takamura M; Toga T; Dong M; Itakura M; Tamura K
Pancreas; 2001 Apr; 22(3):230-9. PubMed ID: 11291923
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer.
Dong M; Zhou JP; Zhang H; Guo KJ; Tian YL; Dong YT
World J Gastroenterol; 2005 May; 11(18):2744-7. PubMed ID: 15884114
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of pBcl-2 and pBax expression in primary invasive ductal pancreatic cancer between Chinese and Japanese patients].
Zhou JP; Dong M; Nio Y; Kong FM; Zheng XY; Guo KJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):611-4. PubMed ID: 16274043
[TBL] [Abstract][Full Text] [Related]
4. Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: effects on clinical outcome and efficacy of adjuvant chemotherapy.
Nio Y; Dong M; Iguchi C; Yamasawa K; Toga T; Itakura M; Tamura K
J Surg Oncol; 2001 Mar; 76(3):188-96. PubMed ID: 11276023
[TBL] [Abstract][Full Text] [Related]
5. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreas.
Nio Y; Omori H; Toga T; Hashimoto K; Itakura M; Koike M; Yano S; Higami T
Anticancer Drugs; 2003 Apr; 14(4):313-9. PubMed ID: 12679736
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis and expression of bcl-2 protein in invasive ductal adenocarcinoma of the pancreas].
Brázdil J; Lukás Z; Hermanová M; Pazourková M; Růzicka M; Habanec B; Kren L; Dítĕ P
Cesk Patol; 2003 Oct; 39(4):168-73. PubMed ID: 14663927
[TBL] [Abstract][Full Text] [Related]
10. Comparative significance of p53 and WAF/1-p21 expression on the efficacy of adjuvant chemotherapy for resectable invasive ductal carcinoma of the pancreas.
Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
Pancreas; 1999 Mar; 18(2):117-26. PubMed ID: 10090408
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients.
Kapranos N; Karaiosifidi H; Valavanis C; Kouri E; Vasilaros S
Anticancer Res; 1997; 17(4A):2499-505. PubMed ID: 9252670
[TBL] [Abstract][Full Text] [Related]
12. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.
Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
Anticancer Res; 1998; 18(5B):3773-9. PubMed ID: 9854494
[TBL] [Abstract][Full Text] [Related]
13. Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.
Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T; Maruyama R
Anticancer Res; 2005; 25(2B):1361-8. PubMed ID: 15865092
[TBL] [Abstract][Full Text] [Related]
14. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma.
Chen D; Zheng X; Kang D; Yan B; Liu X; Gao Y; Zhang K
Med Princ Pract; 2012; 21(1):68-73. PubMed ID: 22024503
[TBL] [Abstract][Full Text] [Related]
16. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.
Sharma J; Srinivasan R; Majumdar S; Mir S; Radotra BD; Wig JD
Pancreas; 2005 May; 30(4):337-42. PubMed ID: 15841044
[TBL] [Abstract][Full Text] [Related]
17. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.
Evans JD; Cornford PA; Dodson A; Greenhalf W; Foster CS; Neoptolemos JP
Pancreatology; 2001; 1(3):254-62. PubMed ID: 12120204
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives.
Minari Y; Nio Y; Hirahara N; Dong M
Cancer Chemother Pharmacol; 2001 May; 47(5):415-22. PubMed ID: 11391857
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers.
Hanaoka T; Nakayama J; Haniuda M; Sato TA
Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
